These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2668243)

  • 41. Tilmicosin does not inhibit interleukin-8 gene expression in the bovine lung experimentally infected with Mannheimia (Pasteurella) haemolytica.
    Goubau S; Morck DW; Buret A
    Can J Vet Res; 2000 Oct; 64(4):238-42. PubMed ID: 11041503
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of calf pneumonia with tilmicosin.
    Fodor L; Varga J; Gallowitsch F; Horváth-Papp I; Miklós G; Lajcsák A; Harmath A
    Acta Vet Hung; 1993; 41(1-2):41-9. PubMed ID: 8116500
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro susceptibility of porcine respiratory pathogens to tilmicosin.
    DeRosa DC; Veenhuizen MF; Bade DJ; Shryock TR
    J Vet Diagn Invest; 2000 Nov; 12(6):541-6. PubMed ID: 11108454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antimicrobial susceptibility of Pasteurella haemolytica and Pasteurella multocida recovered from cattle with bovine respiratory disease complex.
    Post KW; Cole NA; Raleigh RH
    J Vet Diagn Invest; 1991 Apr; 3(2):124-6. PubMed ID: 1892929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effectiveness of tilmicosin in respiratory diseases of swine].
    Binder S; Le NB; Berner H; Bauer J
    Berl Munch Tierarztl Wochenschr; 1993 Jan; 106(1):6-9. PubMed ID: 8431202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mycoplasma bovis isolates from dairy calves in Japan have less susceptibility than a reference strain to all approved macrolides associated with a point mutation (G748A) combined with multiple species-specific nucleotide alterations in 23S rRNA.
    Sato T; Higuchi H; Yokota SI; Tamura Y
    Microbiol Immunol; 2017 Jun; 61(6):215-224. PubMed ID: 28504455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria.
    Budragchaa T; Westermann B; Wessjohann LA
    Bioorg Med Chem; 2019 Aug; 27(15):3237-3247. PubMed ID: 31229422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness and kinetic behaviour of tilmicosin in the treatment of respiratory infections in sheep.
    Naccari F; Giofrè F; Pellegrino M; Calò M; Licata P; Carli S
    Vet Rec; 2001 Jun; 148(25):773-6. PubMed ID: 11465263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antimicrobial evaluation of acyl derivatives of 16-membered macrolide antibiotics related to tylosin.
    Kirst HA; Debono M; Toth JE; Truedell BA; Willard KE; Ott JL; Counter FT; Felty-Duckworth AM; Pekarek RS
    J Antibiot (Tokyo); 1986 Aug; 39(8):1108-22. PubMed ID: 3759662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Terminal stages in the biosynthesis of tylosin.
    Seno ET; Pieper RL; Huber FM
    Antimicrob Agents Chemother; 1977 Mar; 11(3):455-61. PubMed ID: 855999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human exposures to tilmicosin reported to poison centres, Texas, 1998-2003.
    Forrester MB
    Hum Exp Toxicol; 2005 May; 24(5):275-8. PubMed ID: 16004193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro testing of the anti-mycoplasma effect of some anti-coccidial drugs.
    Stipkovits L; Kobulej T; Varga Z; Juhász S
    Vet Microbiol; 1987 Oct; 15(1-2):65-70. PubMed ID: 3439016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves.
    Musser J; Mechor GD; Gröhn YT; Dubovi EJ; Shin S
    J Am Vet Med Assoc; 1996 Jan; 208(1):102-6. PubMed ID: 8682696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spiramycin- and tylosin-resistant strains of Mycoplasma gallisepticum isolated from breeding chickens and pipped eggs.
    Kuniyasu C; Yoshida Y; Takano M
    Natl Inst Anim Health Q (Tokyo); 1974; 14(2):48-53. PubMed ID: 4444733
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of bentonite incorporated in a feed ration with tilmicosin in the prevention of induced Mycoplasma gallisepticum airsacculitis in broiler chickens.
    Shryock TR; Klink PR; Readnour RS; Tonkinson LV
    Avian Dis; 1994; 38(3):501-5. PubMed ID: 7832702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel 16-membered macrolides modified at C-12 and C-13 positions of midecamycin A1 and miokamycin. Part 1: Synthesis and evaluation of 12,13-carbamate and 12-arylalkylamino-13-hydroxy analogues.
    Miura T; Kurihara K; Furuuchi T; Yoshida T; Ajito K
    Bioorg Med Chem; 2008 Apr; 16(7):3985-4002. PubMed ID: 18258437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visualizing the 16-membered ring macrolides tildipirosin and tilmicosin bound to their ribosomal site.
    Poehlsgaard J; Andersen NM; Warrass R; Douthwaite S
    ACS Chem Biol; 2012 Aug; 7(8):1351-5. PubMed ID: 22563863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in chicken phagocytes.
    Scorneaux B; Shryock TR
    Poult Sci; 1998 Oct; 77(10):1510-21. PubMed ID: 9776059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against recent field isolates of Mycoplasma bovis.
    Ayling RD; Baker SE; Peek ML; Simon AJ; Nicholas RA
    Vet Rec; 2000 Jun; 146(26):745-7. PubMed ID: 10909906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The fractional inhibitory concentration index of antimicrobial agents for bacteria and Mycoplasma isolated from the nasal swabs of cattle with respiratory diseases.
    Katoh T; Sakai J; Itagaki M; Watanabe E; Watanabe D; Ogata Y
    J Vet Med Sci; 1996 Aug; 58(8):781-2. PubMed ID: 8877979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.